# Bloodworks, Seattle, WA – FDA Inspections

Source: https://www.keypedia.com/companies/bloodworks/7ecb0a9c-b4a3-41bb-8c61-3be1042e3e8e

> Inspection records and compliance data for Bloodworks in Seattle, Washington. 16 FDA inspections on record (1 OAI), 3 Form 483s, last inspected December 11, 2025.

---

## Details

- Name: Bloodworks
- FEI Number: 3071347
- Address Line 1: 921 Terry Ave
- City: Seattle
- State: Washington
- Zip Code: 98104
- Country Name: United States
- Address: 921 Terry Ave, Seattle, Washington 98104, United States
- Country: United States

## Related Documents

- [483 - Bloodworks - 2025-12-11](https://www.keypedia.com/records/483/bloodworks/d3659a01-54da-4029-bf72-d2878272359f) — source: FDA, date: December 11, 2025
- FDA Inspection 1294906 - Bloodworks - 2025-12-11 — source: FDA, date: December 11, 2025
- [FDA Inspection 1294906 - Bloodworks - 2025-12-11](https://www.keypedia.com/records/fda_inspections/bloodworks/434763ad-6025-46be-a3e0-aafe9ee382fa) — source: FDA, date: December 11, 2025
- [483 - Bloodworks - 2024-05-03](https://www.keypedia.com/records/483/bloodworks/80a76998-4c87-4acc-b8ac-fc1e05a43565) — source: FDA, date: May 3, 2024
- [FDA Inspection 1238690 - Bloodworks - 2024-05-03](https://www.keypedia.com/records/fda_inspections/bloodworks/c6717275-d4f5-4c45-adc7-b32b8f50196e) — classification: No Action Indicated (NAI), source: FDA, date: May 3, 2024
- FDA Inspection 1238690 - Bloodworks - 2024-05-03 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2024
- FDA Inspection 1146276 - Bloodworks - 2021-07-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2021
- FDA Inspection 1146276 - Bloodworks - 2021-07-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2021
- FDA Inspection 1146276 - Bloodworks - 2021-07-16 — classification: No Action Indicated (NAI), source: FDA, date: July 16, 2021
- [FDA Inspection 1087821 - Bloodworks - 2019-04-18](https://www.keypedia.com/records/fda_inspections/bloodworks/ce14ee5e-146d-405d-9e6e-6b2051446a29) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 18, 2019
- FDA Inspection 1056331 - Bloodworks - 2018-06-07 — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2018
- FDA Inspection 1052060 - Bloodworks - 2018-05-04 — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2018

## Related Companies

- [Allermed Laboratories, Inc.](https://www.keypedia.com/companies/allermed-laboratories-inc/6eaaa8cd-b3e9-4008-946a-16ad587c9bbe)
- [Grifols Biologicals LLC](https://www.keypedia.com/companies/grifols-biologicals-llc/817fe827-22a0-42d2-8bb4-2c1e77a30038)
- [CSL Behring AG](https://www.keypedia.com/companies/csl-behring-ag/e5513eac-b911-45b6-b707-dae3d0376210)
- [Instituto Grifols, S.A.](https://www.keypedia.com/companies/instituto-grifols-sa/478ef862-9ed8-4172-919f-c7475c316b61)
- [Quality Bioresources, Inc](https://www.keypedia.com/companies/quality-bioresources-inc/3fa63e69-7126-4059-9bfb-cea6b26ecb7f)
- [Novex Innovations LLC](https://www.keypedia.com/companies/novex-innovations-llc/06b680ca-3c4b-493f-80f0-b316ce40b59c)
- [Nielsen BioSciences, Inc.](https://www.keypedia.com/companies/nielsen-biosciences-inc/13f693a8-14ea-4741-93e8-d0ae89366453)
- [Mesoblast, Inc.](https://www.keypedia.com/companies/mesoblast-inc/f01b1b52-6055-498e-b024-44e07efb950b)
- [Seres Therapeutics Inc](https://www.keypedia.com/companies/seres-therapeutics-inc/351817fa-7d0b-4438-9744-5bcb0723f106)
- [Bozeman Health Deaconess Hospital](https://www.keypedia.com/companies/bozeman-health-deaconess-hospital/772632c9-9992-493f-945d-18da6787e4b1)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)
- [investigator](https://www.keypedia.com/people/kaarin-m-slotte/2960bbe1-17ba-4295-9aa8-2514a1595336)
